TW202026030A - Microneedle sheet and method for manufacturing the same including a sheet-like body and a plurality of microneedles on one side of the sheet-like body - Google Patents

Microneedle sheet and method for manufacturing the same including a sheet-like body and a plurality of microneedles on one side of the sheet-like body Download PDF

Info

Publication number
TW202026030A
TW202026030A TW108101294A TW108101294A TW202026030A TW 202026030 A TW202026030 A TW 202026030A TW 108101294 A TW108101294 A TW 108101294A TW 108101294 A TW108101294 A TW 108101294A TW 202026030 A TW202026030 A TW 202026030A
Authority
TW
Taiwan
Prior art keywords
sheet
microneedle
raw material
microneedles
material liquid
Prior art date
Application number
TW108101294A
Other languages
Chinese (zh)
Other versions
TWI809028B (en
Inventor
永井佐知
舟橋依里
三浦夕佳
Original Assignee
日商日寫股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商日寫股份有限公司 filed Critical 日商日寫股份有限公司
Priority to TW108101294A priority Critical patent/TWI809028B/en
Publication of TW202026030A publication Critical patent/TW202026030A/en
Application granted granted Critical
Publication of TWI809028B publication Critical patent/TWI809028B/en

Links

Images

Landscapes

  • Medicinal Preparation (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

An object of the present invention is to provide microneedles for allowing oily components to be dispersed and held in a substrate, and a method for manufacturing the same. The microneedle sheet 10 includes a sheet-like body 20 and a plurality of microneedles 21 on one side of the sheet-like body 20. The plurality of the microneedles 21 are regularly arranged on the sheet-like body 20, for example, in a lattice shape, a honeycomb shape, or a zigzag shape. In addition, the sheet-like body 20 and the microneedle sheet 10 are integrally constructed by using the same material. The sheet-like body 20 and the microneedles 21 contain a substrate 30 that is soluble in an organism and oily components 31 that are dispersed and held in the substrate 30 as constituent materials.

Description

微針片材及其製造方法Microneedle sheet and manufacturing method thereof

本發明係關於用以使用多數微針對於皮膚的角質層導入目的物質之微針片材及其製造方法。The present invention relates to a microneedle sheet used to introduce a target substance into the stratum corneum of the skin and a method of manufacturing the same.

近年來,微針使用在例如醫療相關領域及美容與健康相關領域的場合增加。例如已利用由多數微針構成的微針片材從皮膚、黏膜等人體的體表進行投予藥物。例如日本特開2010-94414號公報(專利文獻1),揭示一種使具有生物體內溶解性之基材中保有藥劑之微針片材,係藉由使有葡聚醣、硫酸軟骨素、透明質酸等生物體內溶解性材料與藥劑溶於水的原料液來形成微針而得。 (先前技術文獻) (專利文獻)In recent years, the use of microneedles has increased in medical-related fields and beauty and health-related fields. For example, a microneedle sheet composed of a large number of microneedles has been used to administer drugs from the surface of the human body such as skin and mucous membranes. For example, Japanese Patent Application Laid-Open No. 2010-94414 (Patent Document 1) discloses a microneedle sheet in which a drug is contained in a base material that has biodissolvability. The microneedle sheet is made of dextran, chondroitin sulfate, and hyaluronic acid. It is obtained by forming a microneedle with a raw material solution in which an acid and other biologically soluble materials are dissolved in water. (Prior technical literature) (Patent Document)

專利文獻1:日本特開2010-94414號公報Patent Document 1: Japanese Patent Application Publication No. 2010-94414

(發明欲解決之課題)(Problems to be solved by the invention)

如上述習知的微針片材及其製造方法中,於使微針片材含有油性成分時,由於油性成分不易溶解於原料液之溶劑即水,故使用此原料液形成的基材中之油性成分會發生不均勻,多數微針逐根、或逐批的品質可能不安定。又,當使油性成分已乳化的原料液乾燥並形成微針時,在乾燥過程中可能乳化均衡性會變化且微針中之油性成分不均勻。As in the above-mentioned conventional microneedle sheet and its manufacturing method, when the microneedle sheet contains oily components, the oily components are not easily dissolved in the solvent of the raw material liquid, that is, water. Oily ingredients will be uneven, and the quality of most microneedles may be unstable one by one or batch by batch. In addition, when the raw material liquid in which the oily component has been emulsified is dried to form microneedles, the balance of emulsification may change during the drying process and the oily components in the microneedles may be uneven.

本發明係為了解決如上述課題,目的在於提供油性成分分散保持在基材中的微針及其製造方法。 (解決課題之方式)In order to solve the above-mentioned problems, the present invention aims to provide a microneedle in which an oily component is dispersed and held in a base material and a method for manufacturing the same. (The way to solve the problem)

為了達成上述目的,第1發明係一種微針片材,具備片狀本體及形成在片狀本體之多數微針,微針含有具生物體內溶解性之基材及分散保持於基材中的油性成分。In order to achieve the above-mentioned object, the first invention is a microneedle sheet having a sheet-like body and a plurality of microneedles formed in the sheet-like body. The microneedles contain a base material that is soluble in the body and an oily substance dispersed in the base material. ingredient.

若是以此方式構成,則油性成分會均勻地保持在具有生物體內溶解性之基材中,故會成為品質安定的微針。If it is constructed in this way, the oily component will be uniformly held in the base material with biodissolvability, so it will become a microneedle with stable quality.

第2發明,係如第1發明之微針片材,其中,油性成分為香蘭基丁基醚、油溶性維生素C衍生物、視黃醇及其衍生物、還原蝦紅素(astaxanthin)、角鯊烷、來自植物之成分、神經醯胺、生育酚、或該等中之2種以上之混合物。The second invention is the microneedle sheet according to the first invention, wherein the oily components are vanillyl butyl ether, oil-soluble vitamin C derivatives, retinol and its derivatives, reduced astaxanthin, keratin Squalane, plant-derived ingredients, ceramide, tocopherol, or a mixture of two or more of these.

若以此方式構成,為了美容目的而用的該等成分會均勻地保持在具有生物體內溶解性之基材中,故可藉由微針在生物體內溶解而將該等成分均勻地導入到生物體內。If constructed in this way, the components used for cosmetic purposes will be uniformly maintained in the base material with biological solubility, so the microneedles can be dissolved in the organism to uniformly introduce the components into the organism. in vivo.

第3發明係如第1或第2發明之微針片材,其含有0.5~1.0重量%之香蘭基丁基醚作為油性成分。The third invention is the microneedle sheet according to the first or second invention, which contains 0.5 to 1.0% by weight of vanillyl butyl ether as an oily component.

如此方式構成的話,能夠限制香蘭基丁基醚對於生物體內的供給量,故能獲得必要充分的香蘭基丁基醚的效能。With this configuration, the amount of vanillyl butyl ether supplied to the living body can be restricted, so that the necessary and sufficient performance of vanillyl butyl ether can be obtained.

第4發明係如第1至第3發明任一項之微針片材,其中微針中含有0.1至0.2重量%之乳化劑。The fourth invention is the microneedle sheet according to any one of the first to third inventions, wherein the microneedles contain 0.1 to 0.2% by weight of emulsifier.

若為如此的構成,乳化劑會促進油性成分的分散,故能更均勻地將油性成分保持在微針中。With such a configuration, the emulsifier promotes the dispersion of the oily component, so the oily component can be held in the microneedles more uniformly.

第5發明係如第1至第4發明中任一項之微針片材,其中片狀本體和微針為相同材料。The fifth invention is the microneedle sheet according to any one of the first to fourth inventions, wherein the sheet-shaped body and the microneedles are made of the same material.

若為如此的構成,片狀本體中含有油性成分,因此微針片材貼在皮膚時,能藉由片狀本體使為了美容目的而使用的油性成分從皮膚之表面到達皮膚之中。With such a configuration, the sheet-like body contains oily ingredients, so when the microneedle sheet is applied to the skin, the sheet-like body can make oily ingredients used for cosmetic purposes reach the skin from the surface of the skin.

第6發明係一種微針之製造方法,係具片狀本體及形成在片狀本體之多數微針之微針片材之製造方法,具備下列步驟:將生物體內溶解性材料與油性成分添加到溶劑中,獲得油性成分已乳化的原料液;將原料液填充到有因應微針之形狀的多數凹部的模;及使填充於模的原料液乾燥。The sixth invention is a method for manufacturing microneedles. The method for manufacturing a microneedle sheet with a sheet-like body and a large number of microneedles formed on the sheet-like body includes the following steps: adding biologically soluble materials and oily components to In the solvent, a raw material liquid in which oily components have been emulsified is obtained; the raw material liquid is filled into a mold with a large number of recesses corresponding to the shape of the microneedles; and the raw material liquid filled in the mold is dried.

若為如此的構成,使用生物體內溶解性材料與油性成分乳化成的原料液來形成片狀本體及微針,故能夠將油性成分分散保持在由具有生物體內溶解性之基材形成的片狀本體及微針中。With such a configuration, the sheet-shaped body and microneedles are formed using a raw material liquid emulsified from a biologically soluble material and an oily component, so that the oily component can be dispersed and maintained in a sheet formed of a substrate with biological solubility In the body and the microneedle.

第7發明係一種微針片材之製造方法,係具有片狀本體及形成在片狀本體之多數微針之微針片材之製造方法,具備下列步驟:將生物體內溶解性材料與油性成分添加到溶劑中,獲得油性成分已乳化的原料液;將原料液滴加在片狀本體;使滴加在片狀本體的原料液接觸拉提構件;將拉提構件提起而將滴加在片狀本體的原料液形成為針狀;及使形成針狀之原料液乾燥。The seventh invention is a method for manufacturing a microneedle sheet. The method for manufacturing a microneedle sheet having a sheet-like body and a large number of microneedles formed on the sheet-like body includes the following steps: combining the soluble material in the body with the oily component Add it to the solvent to obtain the raw material liquid with emulsified oily ingredients; drop the raw material liquid on the sheet body; make the raw material liquid dripped on the sheet body contact the lifting member; lift the lifting member to drop it on the sheet The raw material liquid of the shaped body is formed into a needle shape; and the needle-shaped raw material liquid is dried.

若為如此的構成,使用生物體內溶解性材料與油性成分乳化而得的原料液來形成微針,故能夠使油性成分分散保持在藉由具有生物體內溶解性之基材形成的微針中。With such a configuration, a raw material liquid obtained by emulsifying an in vivo soluble material and an oily component is used to form the microneedles, so that the oily component can be dispersed and held in the microneedles formed by the base material having in vivo solubility.

第8發明係如第6或第7發明之微針片材之製造方法,其中獲得原料液之步驟,係更添加乳化劑於溶劑中。The eighth invention is the manufacturing method of the microneedle sheet according to the sixth or seventh invention, wherein the step of obtaining the raw material liquid is to add an emulsifier to the solvent.

若為如此的構成,原料液中含有的乳化劑會促進原料液中之油性成分之乳化,故能夠獲得油性成分更均勻地分散的微針片材。 (發明之效果)With such a configuration, the emulsifier contained in the raw material liquid promotes the emulsification of the oily component in the raw material liquid, so that a microneedle sheet in which the oily component is more uniformly dispersed can be obtained. (Effect of Invention)

依照本發明,能獲得品質更好的含有油性成分的微針片材。According to the present invention, a microneedle sheet containing oily ingredients with better quality can be obtained.

然後針對發明之實施形態,邊參照圖式邊説明。Then, the embodiments of the invention will be described with reference to the drawings.

參照圖1(a),依據本發明第1實施形態之微針片材10,具備:片狀本體20,及在片狀本體20其中一面的多數微針21。多數微針21可在片狀本體20上例如以格子狀、蜂巢狀、或鋸齒狀地規則排列,也可不規則地排列。又,也可片狀本體20與微針21使用相同材料而一體地構成。1( a ), the microneedle sheet 10 according to the first embodiment of the present invention includes a sheet-like body 20 and a plurality of microneedles 21 on one side of the sheet-like body 20. The plurality of microneedles 21 can be regularly arranged on the sheet-shaped body 20 in a grid, honeycomb, or zigzag shape, or can also be arranged irregularly. In addition, the sheet-shaped body 20 and the microneedle 21 may be formed integrally using the same material.

片狀本體20係用以保持多數微針21者。片狀本體20之俯面視形狀只要是是做成配合貼附部位之形狀即可,例如使用於眼睛下面時,可做成沿著眼睛下方的線而彎曲的曲玉形狀,使用於口部時,可做成中央部成為空洞的圓環形狀以成為圍繞口周圍的方式。其他形狀可列舉矩形形狀、多角形形狀、或圓形狀。又,片狀本體20之厚度,能夠設為例如:20μm以上500μm以下,較佳為30μm以上100μm以下,以能確保片材全體的機械強度且可因應皮膚之形狀而柔軟地變形。The sheet-shaped body 20 is used to hold a plurality of microneedles 21. The top view shape of the sheet-like body 20 can be any shape that fits the attachment part. For example, when used under the eyes, it can be made into a curved jade shape that curves along the line under the eyes and used in the mouth. At this time, it can be made into a circular ring shape with a hollow center part so as to surround the periphery of the mouth. Other shapes include rectangular shapes, polygonal shapes, or circular shapes. In addition, the thickness of the sheet-like body 20 can be set to, for example, 20 μm or more and 500 μm or less, preferably 30 μm or more and 100 μm or less, so that the overall mechanical strength of the sheet can be ensured and it can be flexibly deformed according to the shape of the skin.

微針21係用於插入到生物體內,對於生物體內導入藥劑者。微針21之形狀例如:圓錐形、圓錐台形、或成層火山形。又,成層火山形,係代表圓錐形或圓錐台形的側面朝內彎曲的形狀。微針21的高度(微針21從片狀本體20突出的高度),可設為例如:10μm以上500μm以下,較佳為50μm以上200μm以下,以使能夠插入到生物體內。微針21之密度可設為例如:100根/cm2 以上500根/cm2 以下。The microneedle 21 is used for insertion into a living body, for those who introduce a drug into the living body. The shape of the microneedle 21 is, for example, a cone shape, a truncated cone shape, or a stratified volcanic shape. In addition, the stratified volcanic shape represents a shape in which the side surface of a cone or truncated cone is curved inward. The height of the microneedle 21 (the height at which the microneedle 21 protrudes from the sheet-like body 20) can be set to, for example, 10 μm or more and 500 μm or less, preferably 50 μm or more and 200 μm or less, so that it can be inserted into a living body. The density of the microneedles 21 may be, for example: 100 / cm 2 or more 500 / cm 2 or less.

片狀本體20及微針21中,含有具有生物體內溶解性之基材30與分散保持在基材30中之油性成分31作為構成材料。片狀本體20及微針21可藉由使溶劑中含有該等構成材料的原料液50乾燥而形成。又,為了促進基材30中之油性成分31分散,也可含有乳化劑32。再者,也可含有基材30、油性成分31之安定化劑等其他添加劑。安定化劑可使用例如:甘油。The sheet-like body 20 and the microneedles 21 contain a base material 30 having in vivo solubility and an oily component 31 dispersed and held in the base material 30 as constituent materials. The sheet-like body 20 and the microneedles 21 can be formed by drying the raw material liquid 50 containing these constituent materials in a solvent. In addition, in order to promote the dispersion of the oily component 31 in the substrate 30, an emulsifier 32 may be contained. Furthermore, other additives such as the stabilizer of the base material 30 and the oily component 31 may be contained. As a stabilizer, for example, glycerin can be used.

原料液50之溶劑可使用例如:水、有機溶劑、或其混合溶劑。For the solvent of the raw material liquid 50, for example, water, an organic solvent, or a mixed solvent thereof can be used.

具有生物體內溶解性之基材30,可使用例如:透明質酸、硫酸軟骨素、聚三葡萄糖(pullulan)、葡聚醣、三仙膠、羅望子膠、糖原、甲殼素、殼聚醣、瓊脂糖、果膠、羧基乙烯基聚合物及該等之衍生物。又、該等材料可單獨使用,也可混用2種以上。The substrate 30 with biological solubility, for example: hyaluronic acid, chondroitin sulfate, pullulan, dextran, trixian gum, tamarind gum, glycogen, chitin, chitosan , Agarose, pectin, carboxyvinyl polymer and their derivatives. In addition, these materials may be used alone, or two or more of them may be mixed.

油性成分31,可使用例如:香蘭基丁基醚、油溶性維生素C衍生物、視黃醇及其衍生物、還原蝦紅素(astaxanthin)、角鯊烷、來自植物之成分、神經醯胺、生育酚、或該等中的2種以上之混合物。該等油性成分31之中,使用香蘭基丁基醚或含香蘭基丁基醚之2種以上之混合物較佳。將使用香蘭基丁基醚作為油性成分31之微針片材10貼附於使用部位時,使用者會因為香蘭基丁基醚而感覺到溫感刺激,故能夠確認微針片材10含有的成分已對於生物體內供給,可獲得一定的使用感。又微針片材10中之香蘭基丁基醚之含量宜為0.5至1.0重量%較佳。香蘭基丁基醚之含量若為0.5重量%以上,能充分獲得香蘭基丁基醚的效能。另一方面,香蘭基丁基醚之含量若為1.0重量%以下,可成為香蘭基丁基醚的效能不會過強的量。As the oily ingredient 31, for example, vanillyl butyl ether, oil-soluble vitamin C derivatives, retinol and its derivatives, astaxanthin, squalane, plant-derived ingredients, ceramide, Tocopherol, or a mixture of two or more of these. Among these oily components 31, it is preferable to use vanillyl butyl ether or a mixture containing two or more types of vanillyl butyl ether. When the microneedle sheet 10 using vanillyl butyl ether as the oily component 31 is attached to the site of use, the user will feel a warm stimulus due to the vanillyl butyl ether, so it can be confirmed that the microneedle sheet 10 contains The ingredients have been supplied to the body, and a certain sense of use can be obtained. In addition, the content of vanillyl butyl ether in the microneedle sheet 10 is preferably 0.5 to 1.0% by weight. If the content of vanillyl butyl ether is 0.5% by weight or more, the performance of vanillyl butyl ether can be fully obtained. On the other hand, if the content of vanillyl butyl ether is 1.0% by weight or less, the effectiveness of vanillyl butyl ether will not be too strong.

乳化劑32可為了促進原料液50中之油性成分31之乳化而使用。材料可使用例如:二月桂醯基麩胺酸離胺酸鈉等非離子性界面活性劑。又,微針片材10中之乳化劑32之含量為0.1重量%~0.2重量%較佳。乳化劑32之含量若為此範圍內,微針片材10不會出現斑點,能夠分散保持油性成分31,而且可以形成無氣泡的微針片材10。The emulsifier 32 can be used to promote the emulsification of the oily component 31 in the raw material liquid 50. As the material, for example, nonionic surfactants such as dilaurin glutamic acid sodium lysine can be used. Moreover, the content of the emulsifier 32 in the microneedle sheet 10 is preferably 0.1% by weight to 0.2% by weight. If the content of the emulsifier 32 is within this range, the microneedle sheet 10 will not have spots, the oily component 31 can be dispersed and maintained, and a bubble-free microneedle sheet 10 can be formed.

然後揭示圖1(a)所示之微針片材10之製造方法。Then, the manufacturing method of the microneedle sheet 10 shown in FIG. 1(a) is disclosed.

顯示原料液50的準備步驟。將係基材30的透明質酸鈉、係油性成分31之香蘭基丁基醚、係乳化劑32之二月桂醯基麩胺酸離胺酸鈉添加到溶劑中。然後使用均質混合機將溶液混合,以獲得油性成分31已乳化的原料液50。The preparation steps of the raw material liquid 50 are shown. The sodium hyaluronate of the base material 30, the vanillyl butyl ether of the oily component 31, and the sodium dilauroglutamate lysine of the emulsifier 32 are added to the solvent. Then, the solution is mixed using a homomixer to obtain a raw material liquid 50 in which the oily component 31 has been emulsified.

然後參照圖2(a),準備有因應微針21之形狀的多數凹部81的模80。然後參照圖2(b),將原料液50填充在模80。然後將原料液50乾燥直到固化為止。然後參照圖2(c),從模80取出已乾燥的微針片材10,以製造圖1(a)所示之微針片材10。Then, referring to FIG. 2(a), a mold 80 having a plurality of recesses 81 corresponding to the shape of the microneedle 21 is prepared. Then, referring to FIG. 2( b ), the raw material liquid 50 is filled in the mold 80. Then, the raw material liquid 50 is dried until solidified. Then, referring to FIG. 2(c), the dried microneedle sheet 10 is taken out from the mold 80 to manufacture the microneedle sheet 10 shown in FIG. 1(a).

由以上,如上述製造之微針片材10因為使用係生物體內溶解性材料的基材30與油性成分31已乳化的原料液50來形成片狀本體20及微針21,故會成為油性成分31分散保持在利用具有生物體內溶解性之基材30形成之片狀本體20及微針21中的微針片材10。From the above, the microneedle sheet 10 manufactured as described above uses the base material 30 of a biologically soluble material and the raw material liquid 50 in which the oily component 31 is emulsified to form the sheet-like body 20 and the microneedle 21, so it becomes an oily component 31. The microneedle sheet 10 is dispersed and held in the sheet-shaped body 20 and the microneedles 21 formed by using a substrate 30 having in vivo solubility.

然後針對本發明之第2實施形態,邊參照圖式邊就和前面的實施形態不同的點進行説明。Next, regarding the second embodiment of the present invention, the differences from the previous embodiment will be described with reference to the drawings.

參照圖1(b),依據本發明第2實施形態之微針片材10中,微針21係藉由具有生物體內溶解性之基材30及分散保持在基材30中之油性成分31構成,此點與第1實施形態一樣。另一方面,片狀本體20不是由和微針21一樣的材料構成,此點不一樣。1(b), in the microneedle sheet 10 according to the second embodiment of the present invention, the microneedles 21 are composed of a base material 30 that is soluble in the body and an oily component 31 dispersed and held in the base material 30 This point is the same as the first embodiment. On the other hand, the sheet-like body 20 is not made of the same material as the microneedle 21, which is different.

片狀本體20只要不是和微針21一樣的材料即可,可使用和第1實施形態之片狀本體20使用之基材30同樣的材料,也可使用有柔軟性的其他材料。材料,例如:紙類、樹脂薄膜、及不織布。As long as the sheet-like body 20 is not the same material as the microneedles 21, the same material as the base material 30 used in the sheet-like body 20 of the first embodiment may be used, or other materials with flexibility may be used. Materials, such as: paper, resin film, and non-woven fabric.

其他材料可使用和本發明第1實施形態同樣的材料。For other materials, the same materials as in the first embodiment of the present invention can be used.

然後揭示圖1(b)所示微針片材10之製造方法。Then, the manufacturing method of the microneedle sheet 10 shown in FIG. 1(b) is disclosed.

首先,和本發明第1實施形態同樣進行,準備使係基材30之透明質酸鈉、係油性成分31之香蘭基丁基醚、係乳化劑32之二月桂醯基麩胺酸離胺酸鈉含於溶劑中,且油性成分31已乳化之原料液50。然後參照圖3(a),在片狀本體20上滴加原料液50。此時,以因應最終獲得之微針21的間隔滴加原料液50。然後參照圖3(b),使滴加在片狀本體20上之原料液50之液滴分別接觸圓柱形狀或角柱形狀之拉提構件60。然後參照圖3(c),將拉提構件60提起而將原料液50之液滴形成針狀。然後使原料液50乾燥直到固化為止,以進行圖1(b)所示之微針片材10之製造。First, in the same manner as in the first embodiment of the present invention, prepare the sodium hyaluronate of the base material 30, the vanillyl butyl ether of the oily component 31, and the dilauric glutamine lysine of the emulsifier 32. The raw material liquid 50 in which sodium is contained in the solvent and the oily component 31 is emulsified. Then, referring to FIG. 3( a ), the raw material liquid 50 is dropped on the sheet body 20. At this time, the raw material liquid 50 is dropped at intervals corresponding to the microneedles 21 finally obtained. Then, referring to FIG. 3(b), the droplets of the raw material liquid 50 dropped on the sheet-shaped body 20 are contacted with the cylindrical or angular column-shaped lifting member 60 respectively. Then, referring to FIG. 3(c), the lifting member 60 is lifted to form the droplets of the raw material liquid 50 into needle shapes. Then, the raw material liquid 50 is dried until solidified, so that the microneedle sheet 10 shown in FIG. 1(b) is manufactured.

由以上,如上述製造之微針片材10,使用了係生物體內溶解性材料的基材30與油性成分31已乳化之原料液50來在片狀本體20上形成微針21,所以,會成為油性成分31分散保持在藉由具有生物體內溶解性之基材30形成之微針21中的微針片材10。From the above, the microneedle sheet 10 manufactured as described above uses the base material 30 which is a biologically soluble material and the raw material liquid 50 in which the oily component 31 has been emulsified to form the microneedles 21 on the sheet body 20. Therefore, This becomes the microneedle sheet 10 in which the oily component 31 is dispersed and held in the microneedles 21 formed of the base material 30 having in vivo solubility.

參照表1揭示依第1實施形態之製造方法所製造之微針片材10之實施例1~實施例6及比較例1~比較例8。各實施例及比較例之微針片材10,係使用透明質酸鈉作為基材30,並於基材30中含有0.5重量%或1.0重量%之作為油性成分31之香蘭基丁基醚、0.05重量%~0.37重量%之作為乳化劑32之二月桂醯基麩胺酸離胺酸鈉。Referring to Table 1, Examples 1 to 6 and Comparative Example 1 to Comparative Example 8 of the microneedle sheet 10 manufactured by the manufacturing method of the first embodiment are disclosed. The microneedle sheet 10 of each embodiment and comparative example uses sodium hyaluronate as the base material 30, and the base material 30 contains 0.5% by weight or 1.0% by weight of vanillyl butyl ether as the oily component 31, 0.05% by weight to 0.37% by weight as an emulsifier 32 bis sodium lauric glutamate lysine.

[表1]   香蘭基丁基醚 (重量%) 二月桂醯基麩胺酸離胺酸鈉(重量%) 有無斑點 有無氣泡 實施例1 0.5 0.10 實施例2 0.5 0.18 實施例3 0.5 0.20 實施例4 1.0 0.10 實施例5 1.0 0.18 實施例6 1.0 0.20 比較例1 0.5 0.05 比較例2 0.5 0.08 比較例3 0.5 0.30 比較例4 0.5 0.37 比較例5 1.0 0.05 比較例6 1.0 0.08 比較例7 1.0 0.30 比較例8 1.0 0.37 [Table 1] Vanillyl Butyl Ether (wt%) Dilaurin Glutamate Sodium Lysine (wt%) Spots Whether there are bubbles Example 1 0.5 0.10 no no Example 2 0.5 0.18 no no Example 3 0.5 0.20 no no Example 4 1.0 0.10 no no Example 5 1.0 0.18 no no Example 6 1.0 0.20 no no Comparative example 1 0.5 0.05 Have Have Comparative example 2 0.5 0.08 no Have Comparative example 3 0.5 0.30 no Have Comparative example 4 0.5 0.37 no Have Comparative example 5 1.0 0.05 Have Have Comparative example 6 1.0 0.08 no Have Comparative example 7 1.0 0.30 no Have Comparative example 8 1.0 0.37 no Have

針對實施例1~實施例6及比較例1~比較例8所示之微針片材10,揭示為了調查乳化劑32之含量之最適範圍而進行之外觀評價之結果。外觀評價係針對是否均勻及是否有氣泡進行。微針片材10出現斑點時,代表油性成分31未分散,故不理想。又微針片材10有氣泡時,針對氣泡導致有損製品外觀之觀點、在有氣泡之部分未形成微針21之點,係不理想。For the microneedle sheet 10 shown in Example 1 to Example 6 and Comparative Example 1 to Comparative Example 8, the results of the appearance evaluation performed to investigate the optimum range of the content of the emulsifier 32 are disclosed. Appearance evaluation is based on whether it is uniform and whether there are bubbles. When the microneedle sheet 10 has spots, it means that the oily component 31 is not dispersed, which is not ideal. In addition, when the microneedle sheet 10 has bubbles, it is undesirable for the viewpoint that the bubbles cause damage to the appearance of the product, and that the microneedles 21 are not formed in the portion where the bubbles exist.

首先針對有無斑點,進行外觀評價。其結果,針對乳化劑32之含量為0.08重量%~0.37重量%之範圍的實施例1~實施例6、比較例2~比較例4及比較例6~比較例8,獲得了無斑點的微針片材10。另一方面,針對乳化劑32之含量為0.05重量%的比較例1及比較例5,確認微針片材10有斑點。First, the appearance is evaluated for the presence or absence of spots. As a result, for Examples 1 to 6, Comparative Example 2 to Comparative Example 4, and Comparative Example 6 to Comparative Example 8 in which the content of the emulsifier 32 was in the range of 0.08% by weight to 0.37% by weight, a spotless microparticle was obtained. Needle sheet 10. On the other hand, in Comparative Example 1 and Comparative Example 5 in which the content of the emulsifier 32 was 0.05% by weight, it was confirmed that the microneedle sheet 10 had spots.

然後針對有無氣泡進行外觀評價。其結果,針對乳化劑32之含量為0.10重量%~0.20重量%之範圍的實施例1~實施例6,獲得了無氣泡的微針。另一方面,針對乳化劑32之含量為0.05重量%、0.08重量%、0.30重量%、0.37重量%的比較例1~比較例8,確認微針片材10有氣泡存在。Then, the appearance was evaluated for the presence or absence of bubbles. As a result, regarding Examples 1 to 6 in which the content of the emulsifier 32 was in the range of 0.10% by weight to 0.20% by weight, microneedles without bubbles were obtained. On the other hand, in Comparative Examples 1 to 8 in which the content of the emulsifier 32 was 0.05% by weight, 0.08% by weight, 0.30% by weight, and 0.37% by weight, it was confirmed that the microneedle sheet 10 had bubbles.

由以上,獲得就乳化劑32之含量而言,0.10重量%~0.20重量%為較佳的結果。乳化劑32之含量藉由為此範圍內,可獲得無斑點及氣泡的微針片材10。From the above, in terms of the content of the emulsifier 32, 0.10% by weight to 0.20% by weight is preferable. With the content of the emulsifier 32 within this range, a microneedle sheet 10 without spots and bubbles can be obtained.

又,本發明之第1實施形態中,片狀本體20與微針21係使用相同材料而一體地構成,但是使用微針片材10時,若可對於生物體內供給油性成分31,則也可對於因應模80之片狀本體20之部分及因應微針21之部分填充不一樣的材料,且片狀本體20與微針21以不一樣材料構成。In addition, in the first embodiment of the present invention, the sheet-like body 20 and the microneedle 21 are integrally constructed using the same material, but when the microneedle sheet 10 is used, if the oily component 31 can be supplied to the living body, it may be The part of the sheet-shaped body 20 of the mold 80 and the part of the micro-needle 21 are filled with different materials, and the sheet-shaped body 20 and the microneedle 21 are made of different materials.

又,在本發明第1實施形態中,若微針片材10之製造步驟中將微針片材10從模80取出但不馬上使用微針片材10,可以不將微針片材10從模80取出而是將模80作為保護微針片材10的保護片使用。Also, in the first embodiment of the present invention, if the microneedle sheet 10 is taken out from the mold 80 in the manufacturing step of the microneedle sheet 10 but the microneedle sheet 10 is not used immediately, the microneedle sheet 10 may not be removed from The mold 80 is taken out and the mold 80 is used as a protective sheet for protecting the microneedle sheet 10.

本發明第2實施形態中,係利用拉提構件60將原料液50形成為針狀,但若為藉由將原料液50乾燥而形成之微針21插入到生物體內的形狀,則也可利用拉提構件60將原料液50形成為圓錐台形、或成層火山形等其他形狀。In the second embodiment of the present invention, the raw material liquid 50 is formed into a needle shape by the pulling member 60, but if the microneedle 21 formed by drying the raw material liquid 50 is inserted into a living body, it can also be used The lifting member 60 forms the raw material liquid 50 into other shapes such as a truncated cone shape or a stratified volcanic shape.

又,本發明第2實施形態中,係使用圓柱形狀或角柱形狀之拉提構件60將原料液50的液滴形成為針狀,但是也可使用平板狀之拉提構件60,同時將多數液滴形成為針狀。In addition, in the second embodiment of the present invention, a cylindrical or angular column-shaped lifting member 60 is used to form the droplets of the raw material liquid 50 into needles, but a flat-plate lifting member 60 may be used to simultaneously transfer most liquid The drop is formed into a needle shape.

又,本發明之上述各實施形態中,為了獲得乳化的原料液50係使用均質混合機來促進原料液50之乳化,但是當原料液50容易乳化時,可不使用均質混合機。In addition, in each of the above embodiments of the present invention, in order to obtain the emulsified raw material liquid 50, a homomixer is used to promote the emulsification of the raw material liquid 50, but when the raw material liquid 50 is easily emulsified, the homomixer may not be used.

10:微針片材 20:片狀本體 21:微針 30:基材 31:油性成分 32:乳化劑 50:原料液 60:拉提構件 80:模 81:凹部10: Microneedle sheet 20: sheet body 21: Microneedle 30: Substrate 31: Oily ingredients 32: emulsifier 50: Raw material liquid 60: Lifting member 80: Mode 81: recess

圖1中,(a)係依據本發明第1實施形態之微針片材之剖面圖,(b)係依據本發明第2實施形態之微針片材之剖面圖。 圖2中,(a)至(c)係顯示圖1(a)所示微針片材之製造步驟之概略圖。 圖3中,(a)至(c)係顯示圖1(b)所示微針片材之製造步驟之概略圖。In FIG. 1, (a) is a cross-sectional view of the microneedle sheet according to the first embodiment of the present invention, and (b) is a cross-sectional view of the microneedle sheet according to the second embodiment of the present invention. In FIG. 2, (a) to (c) are schematic diagrams showing the manufacturing steps of the microneedle sheet shown in FIG. 1(a). In Fig. 3, (a) to (c) are schematic diagrams showing the manufacturing steps of the microneedle sheet shown in Fig. 1(b).

10:微針片材 10: Microneedle sheet

20:片狀本體 20: sheet body

21:微針 21: Microneedle

30:基材 30: Substrate

31:油性成分 31: Oily ingredients

Claims (8)

一種微針片材,具備片狀本體及形成在該片狀本體之多數微針,該微針含有具有生物體內溶解性之基材及分散保持在該基材中之油性成分。A microneedle sheet is provided with a sheet-like body and a plurality of microneedles formed on the sheet-like body. The microneedles contain a substrate with biodissolvability and oily components dispersed and retained in the substrate. 如申請專利範圍第1項之微針片材,其中,該油性成分為香蘭基丁基醚、油溶性維生素C衍生物、視黃醇及其衍生物、還原蝦紅素(astaxanthin)、角鯊烷、來自植物之成分、神經醯胺、生育酚、或該等中的2種以上之混合物。For example, the microneedle sheet of item 1 in the scope of patent application, wherein the oily ingredients are vanillyl butyl ether, oil-soluble vitamin C derivatives, retinol and its derivatives, reduced astaxanthin (astaxanthin), dogfish Alkanes, plant-derived ingredients, ceramide, tocopherol, or a mixture of two or more of these. 如申請專利範圍第1或2項之微針片材,其中含有0.5至1.0重量%之作為該油性成分之香蘭基丁基醚。For example, the microneedle sheet of item 1 or 2 of the scope of patent application contains 0.5 to 1.0% by weight of vanillyl butyl ether as the oily component. 如申請專利範圍第1或2項之微針片材,其中,該微針含有0.1至0.2重量%之乳化劑。For example, the microneedle sheet of item 1 or 2 of the scope of patent application, wherein the microneedle contains 0.1 to 0.2% by weight of emulsifier. 如申請專利範圍第1或2項之微針片材,其中,該片狀本體和該微針為相同材料。For example, the microneedle sheet of item 1 or 2 in the scope of patent application, wherein the sheet-shaped body and the microneedle are made of the same material. 一種微針之製造方法,係具有片狀本體及形成於該片狀本體之多數微針之微針片材之製造方法,具備下列步驟:將生物體內溶解性材料與油性成分添加到溶劑中,獲得油性成分已乳化之原料液;將該原料液填充在具有因應該微針之形狀之多數凹部之模;及使已填充於該模之該原料液乾燥。A method for manufacturing microneedles is a method for manufacturing a microneedle sheet having a sheet-like body and a large number of microneedles formed on the sheet-like body. The method includes the following steps: adding biologically soluble materials and oily components to a solvent, Obtain a raw material liquid in which oily ingredients have been emulsified; fill the raw material liquid in a mold having many recesses corresponding to the shape of the microneedles; and dry the raw material liquid filled in the mold. 一種微針片材之製造方法,係具有片狀本體與形成在該片狀本體之多數微針之微針片材之製造方法,具備下列步驟: 將生物體內溶解性材料與油性成分添加到溶劑中,獲得油性成分已乳化之原料液;將該原料液滴加在該片狀本體;使滴加在該片狀本體之該原料液接觸拉提構件;將該拉提構件提起而將滴加在該片狀本體之該原料液形成為針狀;及使形成為針狀之該原料液乾燥。A method for manufacturing a microneedle sheet is a method for manufacturing a microneedle sheet having a sheet-like body and a plurality of microneedles formed on the sheet-like body, and includes the following steps: Adding the soluble material and oily components in the body to the solvent to obtain the raw material liquid with emulsified oily components; dripping the raw material liquid on the sheet body; contacting and pulling the raw material liquid dripped on the sheet body Member; the lifting member is lifted to form the raw material liquid dropped on the sheet-shaped body into a needle shape; and the raw material liquid formed into a needle shape is dried. 如申請專利範圍第6或7項之微針片材之製造方法,其中,獲得該原料液之步驟係更將乳化劑添加到溶劑中。For example, the method for manufacturing a microneedle sheet according to item 6 or 7 of the scope of patent application, wherein the step of obtaining the raw material liquid is to add an emulsifier to the solvent.
TW108101294A 2019-01-14 2019-01-14 Microneedle sheet and manufacturing method thereof TWI809028B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW108101294A TWI809028B (en) 2019-01-14 2019-01-14 Microneedle sheet and manufacturing method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW108101294A TWI809028B (en) 2019-01-14 2019-01-14 Microneedle sheet and manufacturing method thereof

Publications (2)

Publication Number Publication Date
TW202026030A true TW202026030A (en) 2020-07-16
TWI809028B TWI809028B (en) 2023-07-21

Family

ID=73005009

Family Applications (1)

Application Number Title Priority Date Filing Date
TW108101294A TWI809028B (en) 2019-01-14 2019-01-14 Microneedle sheet and manufacturing method thereof

Country Status (1)

Country Link
TW (1) TWI809028B (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100037389A (en) * 2008-10-01 2010-04-09 연세대학교 산학협력단 Solid microstructure with multi-controlled release and process for preparing the same
US8545741B2 (en) * 2010-04-01 2013-10-01 Nurim Wellness Co. Ltd. Method of manufacturing microstructure
JP6369991B2 (en) * 2015-03-19 2018-08-08 ライオン株式会社 Method for producing microneedle preparation
CN108553408A (en) * 2018-04-23 2018-09-21 中山大学 A kind of topical pain relief microneedle devices and preparation method thereof for neuropathic pain
CN108852963A (en) * 2018-07-20 2018-11-23 华中科技大学同济医学院附属协和医院 A kind of microneedle patch and preparation method thereof for replenishing water and preserving moisture

Also Published As

Publication number Publication date
TWI809028B (en) 2023-07-21

Similar Documents

Publication Publication Date Title
Alkilani et al. Beneath the skin: a review of current trends and future prospects of transdermal drug delivery systems
Caudill et al. Spatially controlled coating of continuous liquid interface production microneedles for transdermal protein delivery
Yu et al. Transdermal delivery of insulin with bioceramic composite microneedles fabricated by gelatin and hydroxyapatite
Moore et al. Trends in drug-and vaccine-based dissolvable microneedle materials and methods of fabrication
JP5800799B2 (en) Microneedle array containing proteoglycan
Queiroz et al. Microneedles as an alternative technology for transdermal drug delivery systems: a patent review
HUE032040T2 (en) Sustained Local Anesthetic Composition Containing SAIB
KR101768710B1 (en) Manufacturing method of eyelash extension patch having wrinkle-improving function
KR20140143216A (en) Soluble microneedle arrays for buccal delivery of vaccines
US20120101457A1 (en) Needle device
ITMI20070798A1 (en) DEVICE FOR RELAXING THE WRINKLES OF HUMAN SKIN
US12005220B2 (en) Microneedle patch for immunostimulatory drug delivery
JP6173616B2 (en) Microneedle sheet and manufacturing method thereof
JP2011020963A (en) Oily preparation for external use, and method for producing the same
EP3600243A1 (en) Extruded depot form for prolonged active substance release
JP2017095427A (en) Dissolution type microneedle pharmaceutical preparation
JP6576596B1 (en) Microneedle sheet and manufacturing method thereof
EP3634342A1 (en) Silicone pad having active ingredients for skin care and against skin aging
TWI752172B (en) microneedle device
TW202026030A (en) Microneedle sheet and method for manufacturing the same including a sheet-like body and a plurality of microneedles on one side of the sheet-like body
Mehta et al. A Review on organogel for skin aging
JP6369991B2 (en) Method for producing microneedle preparation
JP2021528145A (en) Use of electrospun fibers containing nanodispersions and the electrospun fibers to treat wounds
JP6842998B2 (en) Coenzyme Q10 film formulation
CN105832681A (en) Selective, lipophilic, and long-acting beta agonist mono-therapeutic formulations and methods for the cosmetic treatment of adiposity and contour bulging